SCHEMBL22686159

SCHEMBL22686159

FC(F)(F)c1ccc(Oc2ccnc(Cl)c2Cl)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.42
SCN9A Q15858 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
ATM Q13315 1/20 0.41
RAB9A P51151 1/20 0.41
SLC6A4 P31645 2/20 0.39
HTR2A P28223 1/20 0.39
FGFR2 P21802 1/20 0.39
KDR P35968 4/20 0.38
BRAF P15056 3/20 0.38
MAPK14 Q16539 2/20 0.38
TNNI3K Q59H18 2/20 0.38
KMT2A Q03164 1/20 0.37
FFAR1 O14842 2/20 0.36
LTA4H P09960 1/20 0.36
GRM4 Q14833 1/20 0.36
NOS1 P29475 1/20 0.35
AHR P35869 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29331748 0.86 KCNH2 (0.41) KCNH2SCN9AL3MBTL1LMNAMAPT
SCHEMBL30816944 0.84 KCNH2 (0.42) KCNH2SCN9AL3MBTL1RAB9ASLC6A4
SCHEMBL23111617 0.84 KCNH2 (0.42) KCNH2SCN9AL3MBTL1RAB9ASLC6A4
SCHEMBL25338761 0.81 KMT2A (0.43) KCNH2SCN9AL3MBTL1LMNAMAPT
SCHEMBL25340189 0.78 KCNH2 (0.41) KCNH2SCN9ALMNARAB9ALTA4H
SCHEMBL30482536 0.78 KCNH2 (0.41) KCNH2SCN9ALMNARAB9ALTA4H
SCHEMBL17179355 0.78 MEN1 (0.47) KCNH2SCN9AMAPTKMT2A
SCHEMBL7456975 0.77 FGFR2 (0.48) KCNH2LMNAMAPTSLC6A4HTR2A
SCHEMBL25429249 0.73 KCNH2 (0.44) KCNH2SCN9ALMNAMAPTKDR
SCHEMBL19510904 0.72 LMNA (0.46) KCNH2SCN9ALMNAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213074-A1 ABHD12 INHIBITORS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2022-07-07 US disclosed
CN-113939290-A ABHD12 inhibitors and methods of making and using the same H.隆德贝克有限公司 2022-01-14 CN disclosed
WO-2020232153-A1 ABHD12 INHIBITORS AND METHODS OF MAKING AND USING SAME LUNDBECK LA JOLLA RESEARCH CENTER, INC. (US) 2020-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213074-A1 ABHD12 INHIBITORS AND METHODS OF MAKING AND USING SAME ABHD12, SAMHD1, ABHD11 KCNH2 4671/4885SCN9A 4720/4885L3MBTL1 862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.